These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

165 related articles for article (PubMed ID: 27667313)

  • 1. Vitamin D, vitamin A, the primary melanoma transcriptome and survival.
    O'Shea SJ; Davies JR; Newton-Bishop JA
    Br J Dermatol; 2016 Oct; 175 Suppl 2(Suppl Suppl 2):30-34. PubMed ID: 27667313
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Serum 25-hydroxyvitamin D3 levels are associated with breslow thickness at presentation and survival from melanoma.
    Newton-Bishop JA; Beswick S; Randerson-Moor J; Chang YM; Affleck P; Elliott F; Chan M; Leake S; Karpavicius B; Haynes S; Kukalizch K; Whitaker L; Jackson S; Gerry E; Nolan C; Bertram C; Marsden J; Elder DE; Barrett JH; Bishop DT
    J Clin Oncol; 2009 Nov; 27(32):5439-44. PubMed ID: 19770375
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Do vitamin A serum levels moderate outcome or the protective effect of vitamin D on outcome from malignant melanoma?
    Field S; Elliott F; Randerson-Moor J; Kukalizch K; Barrett JH; Bishop DT; Newton-Bishop JA
    Clin Nutr; 2013 Dec; 32(6):1012-6. PubMed ID: 23669635
    [TBL] [Abstract][Full Text] [Related]  

  • 4. 25-Hydroxyvitamin D2 /D3 levels and factors associated with systemic inflammation and melanoma survival in the Leeds Melanoma Cohort.
    Newton-Bishop JA; Davies JR; Latheef F; Randerson-Moor J; Chan M; Gascoyne J; Waseem S; Haynes S; O'Donovan C; Bishop DT
    Int J Cancer; 2015 Jun; 136(12):2890-9. PubMed ID: 25403087
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Folic acid supplementation and malaria susceptibility and severity among people taking antifolate antimalarial drugs in endemic areas.
    Crider K; Williams J; Qi YP; Gutman J; Yeung L; Mai C; Finkelstain J; Mehta S; Pons-Duran C; Menéndez C; Moraleda C; Rogers L; Daniels K; Green P
    Cochrane Database Syst Rev; 2022 Feb; 2(2022):. PubMed ID: 36321557
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Vitamin D supplementation in cutaneous malignant melanoma outcome (ViDMe): a randomized controlled trial.
    De Smedt J; Van Kelst S; Boecxstaens V; Stas M; Bogaerts K; Vanderschueren D; Aura C; Vandenberghe K; Lambrechts D; Wolter P; Bechter O; Nikkels A; Strobbe T; Emri G; Marasigan V; Garmyn M
    BMC Cancer; 2017 Aug; 17(1):562. PubMed ID: 28835228
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Vitamin D deficiency at melanoma diagnosis is associated with higher Breslow thickness.
    Wyatt C; Lucas RM; Hurst C; Kimlin MG
    PLoS One; 2015; 10(5):e0126394. PubMed ID: 25970336
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Is there a causal relationship between vitamin D and melanoma risk? A Mendelian randomization study.
    Liyanage UE; Law MH; ; Barrett JH; Iles MM; MacGregor S
    Br J Dermatol; 2020 Jan; 182(1):97-103. PubMed ID: 31218665
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Vitamin D Supplementation and Disease-Free Survival in Stage II Melanoma: A Randomized Placebo Controlled Trial.
    Johansson H; Spadola G; Tosti G; Mandalà M; Minisini AM; Queirolo P; Aristarco V; Baldini F; Cocorocchio E; Albertazzi E; Zichichi L; Cinieri S; Jemos C; Mazzarol G; Gnagnarella P; Macis D; Tedeschi I; Salè EO; Stucci LS; Bonanni B; Testori A; Pennacchioli E; Ferrucci PF; Gandini S; On Behalf Of The Italian Melanoma Intergroup Imi
    Nutrients; 2021 Jun; 13(6):. PubMed ID: 34199802
    [TBL] [Abstract][Full Text] [Related]  

  • 10. High serum vitamin D level correlates with better prognostic indicators in primary melanoma: A pilot study.
    Lim A; Shayan R; Varigos G
    Australas J Dermatol; 2018 Aug; 59(3):182-187. PubMed ID: 28332194
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Immunohistochemical evaluation of vitamin D receptor (VDR) expression in cutaneous melanoma tissues and four VDR gene polymorphisms.
    La Marra F; Stinco G; Buligan C; Chiriacò G; Serraino D; Di Loreto C; Cauci S
    Cancer Biol Med; 2017 May; 14(2):162-175. PubMed ID: 28607807
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Expression of vitamin D receptor decreases during progression of pigmented skin lesions.
    Brożyna AA; Jozwicki W; Janjetovic Z; Slominski AT
    Hum Pathol; 2011 May; 42(5):618-31. PubMed ID: 21292298
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Vitamin D deficiency is associated with a worse prognosis in metastatic melanoma.
    Timerman D; McEnery-Stonelake M; Joyce CJ; Nambudiri VE; Hodi FS; Claus EB; Ibrahim N; Lin JY
    Oncotarget; 2017 Jan; 8(4):6873-6882. PubMed ID: 28036288
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Decreased vitamin D serum levels at melanoma diagnosis are associated with tumor ulceration and high tumor mitotic rate.
    Moreno-Arrones OM; Zegeer J; Gerbo M; Manrique-Silva E; Requena C; Traves V; Nagore E
    Melanoma Res; 2019 Dec; 29(6):664-667. PubMed ID: 31469708
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Vitamin D receptor gene polymorphisms, serum 25-hydroxyvitamin D levels, and melanoma: UK case-control comparisons and a meta-analysis of published VDR data.
    Randerson-Moor JA; Taylor JC; Elliott F; Chang YM; Beswick S; Kukalizch K; Affleck P; Leake S; Haynes S; Karpavicius B; Marsden J; Gerry E; Bale L; Bertram C; Field H; Barth JH; Silva Idos S; Swerdlow A; Kanetsky PA; Barrett JH; Bishop DT; Bishop JA
    Eur J Cancer; 2009 Dec; 45(18):3271-81. PubMed ID: 19615888
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Wide versus narrow excision margins for high-risk, primary cutaneous melanomas: long-term follow-up of survival in a randomised trial.
    Hayes AJ; Maynard L; Coombes G; Newton-Bishop J; Timmons M; Cook M; Theaker J; Bliss JM; Thomas JM; ; ;
    Lancet Oncol; 2016 Feb; 17(2):184-192. PubMed ID: 26790922
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Causal association between serum 25-Hydroxyvitamin D levels and cutaneous melanoma: a two-sample Mendelian randomization study.
    Cai B; Lin Q; Ke R; Shan X; Yu J; Ni X; Lin X; Wang B
    Front Oncol; 2023; 13():1154107. PubMed ID: 37664026
    [TBL] [Abstract][Full Text] [Related]  

  • 18. 25-hydroxyvitamin D serum levels in patients with high risk resected melanoma treated in an adjuvant bevacizumab trial.
    Lipplaa A; Fernandes R; Marshall A; Lorigan P; Dunn J; Myers KA; Barker E; Newton-Bishop J; Middleton MR; Corrie PG
    Br J Cancer; 2018 Oct; 119(7):793-800. PubMed ID: 30033445
    [TBL] [Abstract][Full Text] [Related]  

  • 19. An inherited variant in the gene coding for vitamin D-binding protein and survival from cutaneous melanoma: a BioGenoMEL study.
    Davies JR; Field S; Randerson-Moor J; Harland M; Kumar R; Anic GM; Nagore E; Hansson J; Höiom V; Jönsson G; Gruis NA; Park JY; Guan J; Sivaramakrishna Rachakonda P; Wendt J; Pjanova D; Puig S; Schadendorf D; Okamoto I; Olsson H; Affleck P; García-Casado Z; Puig-Butille JA; Stratigos AJ; Kodela E; Donina S; Sucker A; Hosen I; Egan KM; Barrett JH; van Doorn R; Bishop DT; Newton-Bishop J
    Pigment Cell Melanoma Res; 2014 Mar; 27(2):234-43. PubMed ID: 24219834
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Vitamin D deficiency in melanoma patients is associated with worse overall survival: a retrospective cohort study.
    Gracia-Darder I; Carrera C; Alamon-Reig F; Puig S; Malvehy J; Podlipnik S
    Melanoma Res; 2022 Oct; 32(5):384-387. PubMed ID: 35979670
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.